Cancer prevention research 2005; 10(4): 232-241
Published online December 30, 2005
© Korean Society of Cancer Prevention
Woo Young Choi1,2, Cheol Park1, Jae-Yoon Lee3, Gi-Young Kim4, Byung Tae Choi5, Won Ho Lee2, Yong-Kee Jeong6 and Yung Hyun Choi1
Agaricus blazei Murill is a traditional herb medicine which has been used for patient suffering from cancer in Oriental medicine. It used to be a source of antitumor and immunoactive compounds in Oriental medicine, and considered a health food in many countries. In the present study, it was examined the biochemical mechanisms of apoptosis by water extract of Agaricus blazei Murill (WEAB) in human lung carcinoma cell line A549. It was found that WEAB could inhibit the cell growth of U937 cells in a dose-dependent manner, which was associated with apoptotic cell death such as formation of apoptotic bodies and DNA fragmentation. Flow cytometry analysis confirmed that WEAB treatment increased populations of apoptotic-sub G1 phase. Apoptosis of A549 cells by WEAB was associated with a down-regulation of anti-apoptotic Bcl-2 expression and an up-regulation of pro-apoptotic Bax expression. WEAB treatment induced the proteolitic activation of caspase-3 and caspase-9, and a concomitant degradation of poly (ADP-ribose) polymerase (PARP) and β-catenin protein. Taken together, these results indicated that the anti-proliferative effects of WEAB were associated with the induction of apoptotic cell death through regulation of several major growth regulatory gene products such as Bcl-2 family expression and caspase protease ativity, and WEAB may have therapeutic potential in human lung cancer treatment. (Cancer Prev Res 10, 232-241, 2005)
Keywords: Agaricus blazei Murill, Apoptosis, Bax, Caspase
Cheung-Yun Jin, Cheol Park, Jin-woo Jeong, Jae Dong Lee and Yung Hyun Choi
Cancer prevention research 2007; 12(2): 98-104Cheol Park, Sook Kyung Hyun, Eun-Woo Lee, Hyun Ju Kwon, Hye Jin Hwang, Byung-Woo Kim and Yung Hyun Choi
Cancer prevention research 2009; 14(3): 274-281Eun Ok Choi, Hye-Jin Hwang, Yung Hyun Choi
J Cancer Prev 2019; 24(1): 11-19 https://doi.org/10.15430/JCP.2019.24.1.11